Innovative drugs and CRO concepts were once again boosted. Cansino hit a 20cm rise or fall, and Harbin Pharmaceutical Co., Ltd. was close to rising or stopping. Yiqiao Shenzhou, Tylomaibo, Jiankai Technology, and Sanyuan Gene rose more than 7%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.